Frequently Asked Questions

The coverage under insurance varies based on the insurance company and the plan opted for by the patient. It is always better to check the inclusion and exclusion with the insurance company itself. In case any assistance is needed insurance desk in the hospital will be available to help.

All your past Medical records- (prescription, Labs, X-rays and other Radiology reports). Health benefits cards (Insurance cards).

Right to have their religious and spiritual needs respected as far as they don't impinge on the policies of the hospital. Respect for personal dignity and privacy during examination, procedure and treatment.Right for protection from physical abuse or neglect. Right to maintain the confidentiality of information regarding patient's disease and treatment in ICU. Informed consent before an invasive procedure, high-risk procedure and treatment, blood and blood product transfusion, anaesthesia and major or minor surgery and organ donations. Right to voice complaints. Right to know the expected cost of treatment. Right to have access to patient’s clinical records. Right to get information on the plan of care, progress and information on their health care needs. Rights to have information and education about their health care needs. The right to know the hospital rules and regulations related to patients. Right to seek an additional opinion regarding clinical care.

Absolutely, Yes, You and members of your family may assess our facility at any time.

You will be getting your report based on the tests done and their reporting time which will be intimated to you while the samples are collected.

You can download the "one aster" app and complete the scheduling person and then else you can call us at 0483-2488000, 0483-3531000. We will help in guiding you through the registration process and book an appointment.

The treatment gap in epilepsy in India ranges from 22% in the urban setting to as high as 90% in villages. The treatment gap has 2 components- People unable to access healthcare services and People who do not adhere to appropriate medical therapy. One million Indians have medically refractory seizures. Approximately 5 -6 lakh people are candidates for epilepsy surgery in India. Still... Just about 500-600 epilepsy surgeries per year are performed.

There are several medical and surgical trials going on for epilepsy treatment in the Western countries. Few of them are enlisted here: XEN1101 As Adjunctive  Therapy In Focal-Onset Epilepsy Stereotactic Laser Ablation For Temporal Lobe Epilepsy Perampanel Study For Infants With Epilepsy Cannabidiol As An Add-On Therapy In Tuberous Sclerosis Complex Focused Ultrasound For Treatment Of Epilepsy

The pharmacological armamentarium against epilepsy has expanded considerably over the last three decades, and currently includes over 30 different antiseizure medications. The new medications which have been added over the past decade by the FDA include Brivaracetam (Levetiracetam derivative), Perampanel (AMPA antagonist), Cenobamate (Carbamate derivative), Everolimus (Rapamycin derivative), Fenfluramine (Amphetamine derivative) and Cannabidiol (Cannabinoid). Among these Brivaracetam and Perampanel are available in India.

At the global level, it is estimated that nearly 70 million people suffer from epilepsy and the prevalence of epilepsy across the globe is estimated to be 5-9 per 1,000 population. There are 12 million people with epilepsy in India, contributing to 1/6th of global burden. In majority of the people with epilepsy ie 70-80%, the seizures can be well-controlled by giving anti-epileptic drugs. The rest 20-30% have medically refractory epilepsy, in these patients advanced modalities of treatment such as dietary therapy, epilepsy surgery and neuromodulation are the emerging therapeutic options.